Cargando…

Global epidemiology of invasive meningococcal disease

Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jafri, Rabab Z, Ali, Asad, Messonnier, Nancy E, Tevi-Benissan, Carol, Durrheim, David, Eskola, Juhani, Fermon, Florence, Klugman, Keith P, Ramsay, Mary, Sow, Samba, Zhujun, Shao, Bhutta, Zulfiqar A, Abramson, Jon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848799/ https://www.ncbi.nlm.nih.gov/pubmed/24016339 http://dx.doi.org/10.1186/1478-7954-11-17

Ejemplares similares

Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014
por: Djingarey, Mamoudou H., et al.
Publicado: (2015)

Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
por: Rubin, Lorry, et al.
Publicado: (2013)

The status of hepatitis B control in the African region
por: Breakwell, Lucy, et al.
Publicado: (2017)

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
por: Alderson, Mark R, et al.
Publicado: (2019)

Meningococcal Disease in South Africa, 1999–2002
por: Coulson, Garry B., et al.
Publicado: (2007)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
por: Gamougam, Kadidja, et al.
Publicado: (2015)

Countries’ interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions
por: Petit, Dörte, et al.
Publicado: (2017)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
por: Sow, Samba O., et al.
Publicado: (2023)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries
por: Vernet, Guy, et al.
Publicado: (2014)

Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density
por: Manigart, Olivier, et al.
Publicado: (2016)

Risk factors for acquisition of meningococcal carriage in the African meningitis belt
por: Cooper, Laura V., et al.
Publicado: (2019)

Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review
por: Alderson, Mark R., et al.
Publicado: (2022)

Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine
por: Caugant, Dominique A., et al.
Publicado: (2012)

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination
por: Holme, Daniel, et al.
Publicado: (2015)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

ROLE OF MENINGOCOCCAL ENDOTOXIN IN MENINGOCOCCAL PURPURA
por: Davis, Charles E., et al.
Publicado: (1974)

Multidisciplinary analysis of invasive meningococcal disease as a framework for continuous quality and safety improvement in regional Australia
por: Taylor, Kathryn A, et al.
Publicado: (2018)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Combined Clinical Audits and Low-Dose, High-frequency, In-service Training of Health Care Providers and Community Health Workers to Improve Maternal and Newborn Health in Mali: Protocol for a Pragmatic Cluster Randomized Trial
por: Zombre, David, et al.
Publicado: (2021)

Public Health Impact After the Introduction of PsA-TT: The First 4 Years
por: Diomandé, Fabien V. K., et al.
Publicado: (2015)

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study
por: Basta, Nicole E., et al.
Publicado: (2018)

Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel
por: Patel, Manisha, et al.
Publicado: (2014)

Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia
por: Haidara, Fadima Cheick, et al.
Publicado: (2023)

Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries
por: Moturi, Edna, et al.
Publicado: (2018)

Meningococcal Bursitis
por: Oda, Rentaro, et al.
Publicado: (2017)

Meningococcal Disease
por: Pollard, Andrew J
Publicado: (2018)

Meningococcic Carriers
Publicado: (1916)

Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022
por: Hancuh, Molly, et al.
Publicado: (2023)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
por: Parikh, Sydel R., et al.
Publicado: (2016)

HIV-2 infection and HIV-1/HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon.
por: Tevi-Benissan, C, et al.
Publicado: (1998)

Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature
por: Guedes, Sandra, et al.
Publicado: (2022)

Active Surveillance for Adverse Events After a Mass Vaccination Campaign With a Group A Meningococcal Conjugate Vaccine (PsA-TT) in Mali
por: Vannice, Kirsten S., et al.
Publicado: (2015)

MODELLING THE IMPACT OF COVID-19 AND ROUTINE MENACWY VACCINATION ON MENINGOCOCCAL CARRIAGE AND DISEASE IN THE UK.
por: Hadley, L., et al.
Publicado: (2023)

Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease
por: VÁZQUEZ, J. A., et al.
Publicado: (2016)

Meningococcal Vaccination:: An Update on Meningococcal Vaccine Recommendations for the Primary Care Physician
por: Nichols, Justin, et al.
Publicado: (2022)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
por: Xu, Juan, et al.
Publicado: (2022)

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt
por: Manigart, Olivier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m27qbktv6p735hoss7uehu7m1p